FreeStyle Libre 3 Sensors Recalled

On Nov. 24, 2025, Abbott Diabetes Care initiated a voluntary recall of select lots of the FreeStyle Libre 3 continuous glucose monitoring sensor. The recall was prompted by reports that some sensors may not accurately display low blood sugar readings, which could affect diabetes management and pose serious health risks, including potential injury or death. FreeStyle Libre 3 is FDA-approved for continuous glucose monitoring in people with diabetes. Patients and providers are encouraged to check affected lot numbers and serial numbers at www.freestylecheck.com and contact Abbott Diabetes Care or the dispensing pharmacy for replacement options. For more information on the recall, see here.